# The effects of valine, lysine and threonine and their optimal combinations on the synthesis of α-casein by MAC-T cells

**Authors:** Min Yang, Xinyu Zhang, Yu Ding, Lewen Xie, Yu Gao, Kangyu Yao, Wanping Ren, Liang Yang, Yankun Zhao, Wei Shao

PMC · DOI: 10.3389/fvets.2026.1780614 · Frontiers in Veterinary Science · 2026-03-18

## TL;DR

This study finds that a specific mix of valine, lysine, and threonine boosts alpha-casein production in MAC-T cells, which could improve milk quality in dairy cows.

## Contribution

The novel contribution is identifying the optimal amino acid combination (valine:lysine:threonine = 36.114:9.027:4.602 mmol/L) that maximizes α-casein synthesis via mTOR pathway activation.

## Key findings

- The optimal amino acid combination (MIX) significantly increased α-casein synthesis compared to individual amino acids.
- MIX upregulated α-casein gene expression and mTOR pathway components at both mRNA and protein levels.
- Rapamycin inhibition confirmed mTOR pathway involvement, and MIX partially reversed its suppressive effects.

## Abstract

This study aims to enhance milk production and quality in dairy cows. Using in vitro cultured MAC-T cells as a model, it seeks to investigate the effects of valine, lysine, and threonine, as well as their optimal combinations, on the synthesis of α-casein by MAC-T cells. Following a 12-h serum starvation period, MAC-T cells were supplemented with varying concentrations of each amino acid individually. The appropriate concentration ranges and optimal levels for valine, lysine, and threonine were determined using ELISA. Response surface methodology was employed to identify the optimal combination of the three amino acids. The resulting α-casein synthesis in the combined treatment group (MIX group) was then compared with that achieved at the individual optimal concentrations and validated by ELISA. Furthermore, mRNA expression levels of the α-casein-encoding gene and key components of the mTOR signaling pathway were analyzed by RT-qPCR, while protein phosphorylation levels were assessed via Western blot. To confirm the functional involvement of the mTOR pathway, a rapamycin-based inhibition assay was conducted. The maximal stimulation of α-casein synthesis in MAC-T cells was observed at valine, lysine, and threonine concentrations of 4 × Val (25.528 mmol/L), 1 × Lys (7.364 mmol/L), and 0.5 × Thr (1.473 mmol/L), respectively. The optimal amino acid combination (MIX) was determined to be valine:lysine:threonine = 36.114:9.027:4.602 mmol/L. α-Casein synthesis in the MIX group was significantly higher than in any individual amino acid supplementation group (p < 0.01). Supplementation with the MIX medium markedly upregulated the relative mRNA expression of α-casein encoding genes (CSN1S1 and CSN1S2) and key components of the mTOR signaling pathway (ragA-D, mTOR, MLST8, RPTOR, EIF4EBP1, EIF4E, S6K1, EEF2, and RPS6), as well as enhanced the phosphorylation levels of mTOR pathway-related proteins (mTOR, S6K1, 4EBP1, RPS6, and eEF2) (p < 0.01). Treatment with rapamycin significantly suppressed the mRNA expression of these genes, reduced protein phosphorylation, and inhibited α-casein synthesis (p < 0.01); however, co-supplementation with the optimal amino acid combination partially alleviated this suppression, indicating a protective regulatory role of the MIX formulation. The optimal combination of valine, lysine, and threonine was determined to be 36.114:9.027:4.602 mmol/L, corresponding to an approximate molar ratio of 8:2:1. This specific ratio significantly promotes α-casein synthesis in MAC-T cells through activation of the mTOR signaling pathway.

## Linked entities

- **Genes:** CSN1S1 (casein alpha s1) [NCBI Gene 1446], CSN1S2 (casein alpha-S2) [NCBI Gene 282209], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], MLST8 (MTOR associated protein MLST8) [NCBI Gene 64223], RPTOR (regulatory associated protein of MTOR complex 1) [NCBI Gene 57521], EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978], EIF4E (eukaryotic translation initiation factor 4E) [NCBI Gene 1977], RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198], EEF2 (eukaryotic translation elongation factor 2) [NCBI Gene 1938], RPS6 (ribosomal protein S6) [NCBI Gene 6194]
- **Proteins:** MTOR (mechanistic target of rapamycin kinase), RPS6KB1 (ribosomal protein S6 kinase B1), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), RPS6 (ribosomal protein S6), EEF2 (eukaryotic translation elongation factor 2)
- **Chemicals:** valine (PubChem CID 1182), lysine (PubChem CID 866), threonine (PubChem CID 205), rapamycin (PubChem CID 5284616)
- **Species:** Bos taurus (taxon 9913)

## Full-text entities

- **Genes:** CSN1S2 (casein alpha-S2) [NCBI Gene 282209], EIF4E (eukaryotic translation initiation factor 4E) [NCBI Gene 281751], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 100139219], MLST8 (MTOR associated protein, LST8 homolog) [NCBI Gene 535236] {aka GBL}, RPTOR (regulatory associated protein of MTOR complex 1) [NCBI Gene 507056], CSN1S1 (casein alpha s1) [NCBI Gene 282208] {aka CSN1}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 509613], EEF2 (eukaryotic translation elongation factor 2) [NCBI Gene 281138] {aka EF-2}, RPS6 (ribosomal protein S6) [NCBI Gene 787914], RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 404181] {aka S6K1}
- **Chemicals:** rapamycin (MESH:D020123), Thr (MESH:D013912), MIX (-), amino acid (MESH:D000596), Val (MESH:D014633), Lys (MESH:D008239)
- **Species:** Bos taurus (bovine, species) [taxon 9913]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13041546/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13041546/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC13041546/full.md

---
Source: https://tomesphere.com/paper/PMC13041546